Seeyond Charles River Laboratories International, Inc. Transaction History
Seeyond
- $1.03 Billion
- Q4 2022
A detailed history of Seeyond transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Seeyond holds 1,989 shares of CRL stock, worth $372,937. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,989
Previous 1,994
0.25%
Holding current value
$372,937
Previous $392,000
10.46%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
694Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$954 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$701 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$399 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$364 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...